post-marketing drug evaluation 上市药物评价
post-marketing drug assessment 药品上市后再评价
post-marketing drug reevaluation 药品上市后评价
study on post-marketing drug 药品上市后研究
Post-marketing drug assessment is now onset in our country, and the research is unsubstantial.
我国的药品上市再评价刚起步,在该领域的研究非常薄弱。
Establishment of assessing model suitable to drug management is vital to settle post-marketing drugs.
因此建立适应药品管理的规范评价模式是再评价的重点,也是需要解决的难点。
To identify the key points of post-marketing drug evaluation and provide technical support for related guidance.
探讨药物上市后评价的关注点,为药物上市后评价指导原则的构建提供技术参考。
应用推荐